0000950123-15-006046.txt : 20150514
0000950123-15-006046.hdr.sgml : 20150514
20150514165621
ACCESSION NUMBER: 0000950123-15-006046
CONFORMED SUBMISSION TYPE: 13F-HR
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20150331
FILED AS OF DATE: 20150514
DATE AS OF CHANGE: 20150514
EFFECTIVENESS DATE: 20150514
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Polaris Venture Management Co. V, L.L.C.
CENTRAL INDEX KEY: 0001439589
IRS NUMBER: 204234752
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 13F-HR
SEC ACT: 1934 Act
SEC FILE NUMBER: 028-16125
FILM NUMBER: 15863739
BUSINESS ADDRESS:
STREET 1: 1000 WINTER STREET
STREET 2: SUITE 3350
CITY: WALTHAM
STATE: MA
ZIP: 02451
BUSINESS PHONE: 781-290-0770
MAIL ADDRESS:
STREET 1: 1000 WINTER STREET
STREET 2: SUITE 3350
CITY: WALTHAM
STATE: MA
ZIP: 02451
13F-HR
1
primary_doc.xml
13F-HR
LIVE
false
true
false
0001439589
XXXXXXXX
03-31-2015
03-31-2015
Polaris Venture Management Co. V, L.L.C.
1000 Winter Street
Suite 3350
Waltham
MA
02451
13F HOLDINGS REPORT
028-16125
N
John Gannon
Authorized Signatory
855-787-3500
/s/ John Gannon
Waltham
MA
05-14-2015
0
7
223829
false
INFORMATION TABLE
2
form13fInfoTable.xml
INFORMATION TABLE FOR FORM 13F
Bind Therapeutics, Inc.
Common Stock
05548N107
11080
2018253
SH
SOLE
2018253
0
0
Fate Therapeutics, Inc.
Common Stock
31189P102
12094
2473186
SH
SOLE
2473186
0
0
Genocea Biosciences, Inc.
Common Stock
372427104
24375
2055230
SH
SOLE
2055230
0
0
Trevena, Inc.
Common Stock
89532E109
24576
3769280
SH
SOLE
3769280
0
0
Cerulean Pharma Inc
Common Stock
15708Q105
29621
3287529
SH
SOLE
3287529
0
0
Ocular Therapeutix, Inc.
Common Stock
67576A100
85230
2030009
SH
SOLE
2030009
0
0
T2 Biosystems, Inc.
Common Stock
89853L104
36853
2374571
SH
SOLE
2374571
0
0